𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pulmonary embolism in a patient with multiple myeloma receiving thalidomide–dexamethasone therapy

✍ Scribed by Wen-Juei Jeng; Ming-Chung Kuo; Lee-Yung Shih; Pao-Hsien Chu

Publisher
Carden Jennings Publishing
Year
2008
Tongue
English
Weight
276 KB
Volume
87
Category
Article
ISSN
0925-5710

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bortezomib, thalidomide, and dexamethaso
Bortezomib, thalidomide, and dexamethasone as induction therapy for patients with symptomatic multiple myeloma : A retrospective study
✍ Jonathan L. Kaufman; Ajay Nooka; Mark Vrana; Charise Gleason; L. Thompson Heffne 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

## Abstract ## BACKGROUND: This single‐center retrospective study determined the efficacy of bortezomib, thalidomide, and dexamethasone (BTD) as induction for patients with multiple myeloma (MM) who were eligible for autologous stem cell transplantation (ASCT). ## METHODS: Patients with symptoma

Thalidomide and dexamethasone therapy of
Thalidomide and dexamethasone therapy of myeloma in a patient with previously untreated B-chronic lymphocytic leukemia
✍ James C. Barton 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 2 views

## Abstract A 67‐year‐old woman with previously untreated lambda‐positive B‐chronic lymphocytic leukemia (CLL) had kappa‐positive myeloma develop that was treated with daily thalidomide and intermittent dexamethasone. After 4 months, there was a marked reduction in marrow plasmacytosis, urine kappa